PARP inhibitors: a treatment option for AML?

Nat Med. 2015 Dec;21(12):1393-4. doi: 10.1038/nm.4007.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism*
  • Oncogenes*
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use*
  • Transcription Factors / metabolism*

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • Transcription Factors